VynMed Inc. holds a granted U.S. utility patent.
Issued to founder Walter Bischoff Jr, VynMed Inc. owns a granted U.S. utility patent for the original personal, reusable infection-status passport device the company was built on.
What the patent describes
US Patent 12,308,098 B1, "Personal and reusable infection status passport device," describes a countertop device and associated method that combines sample intake, secure chain-of-custody, and tamper-evident reporting in a single, facility-owned workflow.
It reflects the company's origins: a reusable, facility-controlled approach to turning a point-of-care test into a defensible, auditable record.
Independent claims at a glance
- A personal, reusable infection-status passport device.
- An on-device chain-of-custody step that binds sample, timestamp, and identity at the moment of capture.
- A reporting pipeline that produces a tamper-evident record suitable for audit and recordkeeping review.
Why a granted patent matters
Examined IP
VynMed Inc.'s core method was examined and granted by the USPTO, not merely filed — a credibility signal for partners and buyers evaluating the company.
Method, not consumable
The granted claims are directed at a reusable method rather than any single strip, reagent, or supplier.
Foundation to build on
The invention spans related use cases (infection status, medication adherence, occupational health), giving VynMed Inc. an IP foundation to build from.
Patented vs. patent-pending
In this category it is common to point at a provisional filing. VynMed Inc.'s core IP is a granted United States utility patent, already examined and issued by the USPTO. The claims have been through substantive review, not just paid for and stamped "pending."
If you need the exact file wrapper or want your counsel to review the claims directly, we're happy to share the issued patent document under a short evaluation NDA.
Questions about the patent?
Ask for the issued patent document, shared under a short evaluation NDA.
Contact us